Ketankumar Vaidya, MD
Geriatric Medicine · Edison, NJNPI 1487688586
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.2% of the total across 447 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 38 manufacturers, the largest accounting for just 23.2% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $1,795 and has fallen 64.2% since, to $643 in 2025. Among geriatric medicine clinicians in NJ with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 447 payments — averaging $18.23 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$2K
- Nevro Corp.$906
- AstraZeneca$737
- Novartis$705
- Johnson & Johnson$451
- Lilly USA, LLC$399
- plus $3K from 32 others
What the payments were for
- Food & beverage$7,99998%
- Education$1502%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 169 | $1,891 |
| Nevro Corp. | 9 | $906 |
| AstraZeneca(2 entities) | 22 | $737 |
| Novartis | 43 | $705 |
| Johnson & Johnson | 36 | $451 |
| Lilly USA, LLC | 36 | $399 |
| Medtronic | 3 | $385 |
| Bayer | 13 | $325 |
| Merck | 18 | $247 |
| Boston Scientific | 3 | $246 |
| AbbVie | 17 | $205 |
| GSK | 6 | $201 |
| Dexcom, Inc. | 5 | $164 |
| Sanofi-aventis U.S. LLC | 3 | $149 |
| Sanofi | 1 | $124 |
| Exact Sciences | 6 | $110 |
| Astellas Pharma US Inc | 1 | $99 |
| Pfizer | 6 | $91 |
| Arbor Pharmaceuticals, Inc. | 5 | $77 |
| Boehringer Ingelheim | 6 | $75 |
| Acadia Pharmaceuticals Inc | 5 | $74 |
| Vanda Pharmaceuticals Inc. | 4 | $61 |
| Eisai Inc. | 4 | $59 |
| Sunovion Pharmaceuticals Inc. | 4 | $57 |
| Amgen | 3 | $41 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 3 | $40 |
| Otsuka America Pharmaceutical, Inc. | 2 | $31 |
| Neurocrine Biosciences, Inc. | 2 | $29 |
| Abbott | 2 | $27 |
| Daiichi Sankyo Inc. | 2 | $26 |
| Axsome Therapeutics, Inc. | 1 | $17 |
| Cequr Corporation | 1 | $17 |
| Lundbeck LLC | 1 | $16 |
| Scilex Pharmaceuticals Inc. | 1 | $14 |
| Mylan Specialty L.p. | 1 | $13 |
| IBSA Pharma Inc. | 1 | $13 |
| Teva Pharmaceuticals USA, Inc. | 1 | $13 |
| Nestle Healthcare Nutrition Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Omnia$351
- CoreValve Evolut$188
- LEQVIO$135
- INTELLIS$131
- LOKELMA$130
- BREZTRI$130
- FARXIGA$130
- AIRSUPRA$125
- RYBELSUS$125
- Kerendia$125
- XARELTO$125
- SOLIQUA 100/33$124
- TRELEGY ELLIPTA$124
- ENTRESTO$124
- DUPIXENT$124
- Ozempic$120
- GENERAL PAIN MANAGEMENT$119
- Senza$106
- DEXCOM G6 TRANSMITTER$104
How this compares
$8,149 in reported general payments places this provider in the 95th percentile of 165 geriatric medicine providers in New Jersey.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Diclofenac Sodium | 605 | $405,807 |
| TrulicityDulaglutide | 280 | $311,895 |
| FarxigaDapagliflozin Propanediol | 365 | $278,410 |
| JardianceEmpagliflozin | 293 | $235,509 |
| EliquisApixaban | 434 | $230,289 |
| EntrestoSacubitril/Valsartan | 240 | $202,546 |
| JanumetSitagliptin Phos/Metformin Hcl | 237 | $159,615 |
| LinzessLinaclotide | 267 | $157,549 |
| Omeprazole-Sodium BicarbonateOmeprazole/Sodium Bicarbonate | 36 | $131,293 |
| JanuviaSitagliptin Phosphate | 159 | $110,329 |
| OzempicSemaglutide | 64 | $87,014 |
| MounjaroTirzepatide | 73 | $82,139 |
| Metformin Er GastricMetformin Hcl | 38 | $81,230 |
| XareltoRivaroxaban | 129 | $64,513 |
| RybelsusSemaglutide | 57 | $57,313 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCTrulicity, Mounjaro | $399 | $394,034353 claims |
| AstraZenecaFarxiga, Lokelma, Brilinta | $737 | $343,703471 claims |
| MerckJanumet, Januvia, Verquvo, Janumet Xr | $247 | $293,617440 claims |
| Boehringer IngelheimJardiance, Tradjenta, Jentadueto | $75 | $291,586384 claims |
| PfizerEliquis | $91 | $230,289434 claims |
| NovartisEntresto | $705 | $202,546240 claims |
| AbbVieLinzess, Restasis | $205 | $178,727290 claims |
| Novo NordiskOzempic, Rybelsus | $1,891 | $144,327121 claims |
| Johnson & JohnsonXarelto, Procrit | $451 | $116,203168 claims |
| GSKTrelegy Ellipta, Breo Ellipta | $201 | $68,125121 claims |
| AmgenProlia | $41 | $25,01015 claims |
| Astellas Pharma US IncMyrbetriq | $99 | $22,13541 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 165 geriatric medicine providers in New Jersey.
Other geriatric medicine in Edison
- Gerardo EstevezEdison$4K
- Pankaj GuptaEdison$2K
- Albert RiddleHaworth$524K
- Gamil MakarClifton$82K
- Joshua Shua HaimManchester$45K
- Pradip ShahWest Caldwell$27K
- Gregorio GuillenPerth Amboy$8K
- Cheng-An MaoClifton$8K
- Theresa RedlingLivingston$7K
- Sarita RastogiHackensack$7K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.